Company · XYL
Xylem Inc.
Nasdaq's symbol directory lists XYL on the New York Stock Exchange as “Xylem Inc. Common Stock New”.
In the 12 months to Nov 19, 2026: insiders bought on 1 occasion ($986K); 1 planned-sale notice; 8 congressional trade disclosures; 7 company reports (Form 8-K, since May 26, 2026).
Insider trades · SEC Form 4
Those inside the hall
Open-market purchases and sales only. Legs one person filed for one day are combined.
Who traded
- D. Christian Koch bought $986K
Every trade (1)
- BUYD. Christian Koch bought $986K
Planned sales · SEC Form 144
Notice given
A Form 144 is filed before an insider sells restricted stock. It states an intent; the sale, if it happens, appears later on a Form 4. Every recent notice
- McGann Michael J. $562K
Congress · STOCK Act
The Althing
Periodic transaction reports. Amounts are the ranges members report; the trade date is when it happened, the report can come up to 45 days later.
- Rohit Khanna (D-CA17): Purchase $1,001 - $15,000
- Rohit Khanna (D-CA17): Sale $1,001 - $15,000
- Rohit Khanna (D-CA17): Purchase $1,001 - $15,000
- Rohit Khanna (D-CA17): Purchase $1,001 - $15,000
- Rohit Khanna (D-CA17): Sale $1,001 - $15,000
- Rohit Khanna (D-CA17): Purchase $1,001 - $15,000
- Rohit Khanna (D-CA17): Sale $1,001 - $15,000
- Rohit Khanna (D-CA17): Purchase $1,001 - $15,000
Executive branch · OGE Form 278-T
Reported by the President
7 confirmed trades on scanned reports whose security name matches this company's own filed name exactly (letter case, punctuation and Inc/Corp-style endings aside). All of Donald J. Trump's reports
- Sale: XYLEM INC $15,001 – $50,000
- Purchase: XYLEM INC $1,001 – $15,000
- Sale: XYLEM INC $1,001 – $15,000
- Sale: XYLEM INC $1,001 – $15,000
- Sale: XYLEM INC $50,001 – $100,000
- Sale: XYLEM INC $100,001 – $250,000
- Sale: XYLEM INC $1,001 – $15,000
Company reports · SEC Form 8-K
In its own words
Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.
- Other events Nov 13, 2026
- Results of operations and financial condition; Departure or appointment of directors or officers Oct 27, 2026
- Other events Sep 29, 2026
- Entry into a material definitive agreement; Termination of a material definitive agreement; Creation of a direct financial obligation Sep 9, 2026
- Departure or appointment of directors or officers; Regulation FD disclosure Aug 18, 2026
- Departure or appointment of directors or officers Aug 13, 2026
- Results of operations and financial condition Jul 28, 2026
Lobbying · Senate LDA reports
Lobbying filed
3 quarterly lobbying reports for 2026 naming Xylem Inc. as the client: 1 filed by the company itself, 2 by outside firms it hired. Each line is one report as filed; an amended report is a line of its own. An outside firm states what the company paid it; the company's own report states its whole lobbying spend, which can include those fees, so the lines are not added up. Reports are collected in batches and a quarter can be missing here; the full record is at lda.gov.
- The company itself $70K
- MEHLMAN CONSULTING, INC. $50K
- ENS RESOURCES, INC. $20K
Federal contracts · USAspending.gov
Federal contracts
11 contract awards first obligated in the last 12 months to the company or a subsidiary it lists in its 10-K, $1.4M in total obligated as USAspending.gov lists each award when Lytir last read it. Largest first.
- Department of Defense $483K
- Department of Defense $334K
- Department of Veterans Affairs $121K
- Department of Defense $106K
- Department of Defense $92K
- Department of Commerce $89K
- Department of Homeland Security $67K
- General Services Administration $61K
- General Services Administration $44K
- Department of Justice $25K
- Department of Justice $23K
Sources: SEC EDGAR (Forms 4, 144 and 8-K), Senate LDA lobbying reports, USAspending.gov, OGE Form 278-T reports on whitehouse.gov and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.